EE+ POEM Archive
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "No Net Benefit for Ticagrelor Plus Aspirin Over Aspirin Alone in Patients With T2DM and Stable Coronary Disease." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease.
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease. Accessed September 27, 2022.
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease
No Net Benefit for Ticagrelor Plus Aspirin Over Aspirin Alone in Patients With T2DM and Stable Coronary Disease [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2022 September 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease
ID - 1314901
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/No_net_benefit_for_ticagrelor_plus_aspirin_over_aspirin_alone_in_patients_with_T2DM_and_stable_coronary_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
